A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)

NCT05755737 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Vasovagal Syncope (VVS)
Syncope

Interventions

DRUG: Ondansetron
DRUG: Placebo

Sponsor

University of Calgary